As payers increasingly stifle new drug launches, investors in biopharmaceutical companies pursue better sources of insights.
Nora Tsivgas
Advertisement
Articles by Nora Tsivgas
Advertisement
Latest Updated Articles
For Payer Research, High Stakes are the Mother of All InventionPublished: October 4th 2019 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients
2
Report: FDA to Change Vaccine Approval Process Based on Agency’s Claim of Covid Vaccine-Related Deaths
3
Korea and Australia's P&MA Shift: From Local Launch Opportunities to Regional Blueprint
4
Pharmaceutical Executive Daily: U.S. & U.K. Agree to 0% Tariffs on Pharmaceutical Products
5
